High cost patented drugs now account for 50% of sales

Patented Medicine Prices Review Board

25 March 2021 - Federal Minister of Health tables the 2019 Annual Report of the Patented Medicine Prices Review Board

The Honourable Patty Hajdu, Federal Minister of Health, tabled the 2019 Annual Report of the Patented Medicine Prices Review Board (PMPRB) with the Clerks of the House of Commons and the Senate.

Read Patented Medicine Prices Review Board press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Canada , Expenditure